Live feed12:30:00·231dPRReleasevia QuantisnowXencor Presents Initial Data for XmAb819, a First-in-class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Clear Cell Renal Cell CarcinomaByQuantisnow·Wall Street's wire, on your screen.XNCR· Xencor Inc.Health Care
